ENG and preeclampsia: Circulating levels of soluble endoglin have been shown to be higher in the serum of patients with preeclampsia, hypercholesterolemia, atherosclerosis, diabetes mellitus and hypertension [5–8], diseases which all have a significant inflammatory component [2,3].